Melissa Hoffman

Melissa Hoffman is a Principal Scientist at Vividion Therapeutics, Inc., with a progressive tenure that includes roles as Senior Scientist, Scientist II, and Proteomics Scientist since July 2020. Prior experience includes serving as a Clinical Chemistry Fellow at the University of California San Diego from July 2018 to July 2020 and completing a Ph.D. in Oncology and Cancer Biology at Moffitt Cancer Center and the University of South Florida from 2013 to 2018, with a focus on quantitative proteomics in cancer biology under the mentorship of John Koomen, Ph.D. Earlier roles include an Organic Chemistry Tutor at California State University, Chico, and research on microRNA in diabetes as an Undergraduate Student Researcher in the Keller Lab. Education includes a Bachelor of Science in Cell/Cellular and Molecular Biology from California State University, Chico, and prior studies at Butte College.